Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

BUY
$25.89 - $29.73 $163,469 - $187,715
6,314 New
6,314 $175,000
Q3 2023

Oct 25, 2023

BUY
$32.09 - $37.51 $96 - $112
3 Added 0.03%
9,125 $302,000
Q2 2023

Jul 14, 2023

SELL
$36.12 - $41.79 $2,275 - $2,632
-63 Reduced 0.69%
9,122 $334,000
Q1 2023

Apr 12, 2023

SELL
$39.39 - $51.28 $43,841 - $57,074
-1,113 Reduced 10.81%
9,185 $374,000
Q4 2022

Jan 18, 2023

BUY
$41.75 - $54.5 $78,490 - $102,460
1,880 Added 22.33%
10,298 $0
Q3 2022

Oct 14, 2022

BUY
$43.76 - $53.42 $10,458 - $12,767
239 Added 2.92%
8,418 $368,000
Q2 2022

Jul 13, 2022

BUY
$46.53 - $55.17 $9,352 - $11,089
201 Added 2.52%
8,179 $429,000
Q1 2022

Apr 12, 2022

SELL
$45.75 - $56.69 $1,464 - $1,814
-32 Reduced 0.4%
7,978 $413,000
Q4 2021

Jan 26, 2022

SELL
$41.32 - $61.25 $29,543 - $43,793
-715 Reduced 8.19%
8,010 $473,000
Q2 2021

Jul 09, 2021

SELL
$35.91 - $40.68 $215 - $244
-6 Reduced 0.07%
8,725 $342,000
Q1 2021

Apr 20, 2021

SELL
$33.49 - $37.77 $19,591 - $22,095
-585 Reduced 6.28%
8,731 $316,000
Q4 2020

Jan 25, 2021

BUY
$33.47 - $42.56 $10,710 - $13,619
320 Added 3.56%
9,316 $343,000
Q3 2020

Oct 21, 2020

BUY
$31.75 - $37.25 $87,312 - $102,437
2,750 Added 44.03%
8,996 $330,000
Q2 2020

Aug 05, 2020

BUY
$30.12 - $36.54 $188,129 - $228,228
6,246 New
6,246 $204,000
Q1 2020

May 21, 2020

SELL
$27.03 - $38.62 $158,017 - $225,772
-5,846 Closed
0 $0
Q4 2019

Jan 30, 2020

BUY
$32.92 - $37.36 $192,450 - $218,406
5,846 New
5,846 $229,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Life Steps Financial, Inc. Portfolio

Follow Life Steps Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Life Steps Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Life Steps Financial, Inc. with notifications on news.